Publication
A comparative study to analyse the potential of 99mTc-PEI-MP for diagnosis and 188Re-PEI-MP for therapy of bladder carcinoma and osteosarcoma
dc.contributor.author | Ferreira, Sara | |
dc.contributor.author | Laranjo, Mafalda | |
dc.contributor.author | Abrantes, Ana Margarida | |
dc.contributor.author | Brito, Ana | |
dc.contributor.author | Metello, Luís F. | |
dc.contributor.author | Zeevart, Jan | |
dc.contributor.author | Louw, Werner | |
dc.contributor.author | Dormehl, Irene | |
dc.contributor.author | Botelho, Maria Filomena | |
dc.date.accessioned | 2015-09-04T11:09:34Z | |
dc.date.available | 2015-09-04T11:09:34Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Introduction: The water-soluble polymer PEI-MP (polyethyleneimine, functionalised with methylphosphonate groups) that might be labeled with 188Re (emits high energy B- particles) and 99mTc presents a strong potential for metabolic radiotherapy and diagnosis, respectively. The aim of this study was to evaluate in vivo the potential of 188Re-PEI-MP as therapeutic agent and 99mTc-PEI-MP asdiagnostic agent for bladder carcinoma and osteosarcoma. Material and methods: Cytotoxicity of PEI-MP was investigated in bladder carcinoma cell line (CRL-1472) using the MTT test for different concentrations of PEI-MP (1 uM to 1000 uM) and incubation times (24h, 48h, 72h and 96h). | en |
dc.identifier.uri | http://hdl.handle.net/10400.22/6627 | |
dc.language.iso | eng | por |
dc.peerreviewed | no | por |
dc.title | A comparative study to analyse the potential of 99mTc-PEI-MP for diagnosis and 188Re-PEI-MP for therapy of bladder carcinoma and osteosarcoma | por |
dc.type | other | |
dspace.entity.type | Publication | |
oaire.citation.title | World Molecular Imaging Congress | por |
rcaap.rights | openAccess | por |
rcaap.type | other | por |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: